TBRG vs TDOC

For growth investors, TruBridge, Inc.

(TBRG) is the stronger pick with 1. 2% revenue growth year-over-year, versus -1. 5% for Teladoc Health, Inc. (TDOC). TruBridge, Inc. (TBRG) offers the better valuation at 88. 9x trailing P/E (10. 1x forward), making it the more compelling value choice. Analysts rate TruBridge, Inc. (TBRG) a "Hold" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, TruBridge, Inc.

(TBRG) delivered a total return of -17. 4%, compared to -95. 4% for Teladoc Health, Inc. (TDOC). Over 10 years, the gap is even starker: TBRG returned -36. 0% versus TDOC's -41. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), TruBridge, Inc.

(TBRG) is the lower-risk stock at 0. 94β versus Teladoc Health, Inc. 's 1. 91β — meaning TDOC is approximately 103% more volatile than TBRG relative to the S&P 500. On balance sheet safety, Teladoc Health, Inc. (TDOC) carries a lower debt/equity ratio of 75% versus 94% for TruBridge, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), TruBridge, Inc.

(TBRG) is pulling ahead at 1. 2% versus -1. 5% for Teladoc Health, Inc. (TDOC). On earnings-per-share growth, the picture is similar: TruBridge, Inc. grew EPS 121. 0% year-over-year, compared to 80. 6% for Teladoc Health, Inc.. Over a 3-year CAGR, TBRG leads at 2. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

TruBridge, Inc.

(TBRG) is the more profitable company, earning 1. 3% net margin versus -7. 9% for Teladoc Health, Inc. — meaning it keeps 1. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TBRG leads at 9. 7% versus -10. 4% for TDOC. At the gross margin level — before operating expenses — TDOC leads at 69. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

Analyst consensus price targets imply the most upside for TDOC: 8.

9% to $7. 58.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, TruBridge, Inc.

(TBRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94)). Teladoc Health, Inc. (TDOC) carries a higher beta of 1. 91 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TBRG: -36. 0%, TDOC: -41. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.